D050071Chemicals & DrugsD27.505.696.2424100.989751Bone Density Conservation Agentscmhprofilesont:personsuffixperson suffixFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation Resourcevivo:orcidIdORCID idPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonMDBradleyWaradyBradley A. Warady0.000000000000000.0000000000000063Warady, BradleyDirector, Division of Pediatric Nephrology 1Professor28332096Webb NJA, Lerner G, Warady BA, Dell KM, Greenbaum LA, Ariceta G, Hoppe B, Linde P, Lee HJ, Eldred A, Dufek MBPediatric nephrology (Berlin, Germany)Webb NJA, Lerner G, Warady BA, Dell KM, Greenbaum LA, Ariceta G, Hoppe B, Linde P, Lee HJ, Eldred A, Dufek MB. Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney disease. Pediatr Nephrol. 2017 Jul; 32(7):1221-1232.Pediatr Nephrol2017-03-22T00:00:002017Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney disease.1.473540.1522224research area of0.9477110.087516210subject area forPhD, MSHung-WenYehHung-Wen Yeh0.000000000000000.00000000000000136Yeh, Hung-Wen0000-0002-9904-3275Research Faculty PhD28770449Khan QJ, Kimler BF, Reddy PS, Sharma P, Klemp JR, Nydegger JL, Yeh HW, Fabian CJBreast cancer research and treatmentKhan QJ, Kimler BF, Reddy PS, Sharma P, Klemp JR, Nydegger JL, Yeh HW, Fabian CJ. Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial. Breast Cancer Res Treat. 2017 Nov; 166(2):491-500.Breast Cancer Res Treat2017-08-02T00:00:002017Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial.PediatricsResearchClinicalMD, FASNTarakSrivastavaTarak Srivastava39.08346750000000-94.5771129000000043Srivastava, TarakPediatric NephrologyChildren's Mercy Kansas CityMD, FAAP, FACMG, CCDEricRushEric T. Rush0.000000000000000.00000000000000200Rush, Eric0000-0002-8147-7315Medical Director, Office of Faculty Affairs and Development21904199Winston MJ, Srivastava T, Jarka D, Alon USThe Clinical journal of painWinston MJ, Srivastava T, Jarka D, Alon US. Bisphosphonates for pain management in children with benign cartilage tumors. Clin J Pain. 2012 Mar-Apr; 28(3):268-72.Clin J Pain2012-03-01T00:00:002012Bisphosphonates for pain management in children with benign cartilage tumors.28917085Kreikemeier RM, Gosnell H, Halbur LM, Rush ETJournal of pediatric endocrinology & metabolism : JPEMKreikemeier RM, Gosnell H, Halbur LM, Rush ET. A retrospective review of initial bisphosphonate infusion in an inpatient vs. outpatient setting for bisphosphonate na?ve patients. J Pediatr Endocrinol Metab. 2017 Oct 26; 30(10):1105-1110.J Pediatr Endocrinol Metab2017-10-26T00:00:002017A retrospective review of initial bisphosphonate infusion in an inpatient vs. outpatient setting for bisphosphonate na?ve patients.36658750Liu W, Lee B, Nagamani SCS, Nicol L, Rauch F, Rush ET, Sutton VR, Orwoll EThe Journal of clinical endocrinology and metabolismLiu W, Lee B, Nagamani SCS, Nicol L, Rauch F, Rush ET, Sutton VR, Orwoll E. Approach to the Patient: Pharmacological Therapies for Fracture Risk Reduction in Adults With Osteogenesis Imperfecta. J Clin Endocrinol Metab. 2023 06 16; 108(7):1787-1796.J Clin Endocrinol Metab2023-06-16T00:00:002023Approach to the Patient: Pharmacological Therapies for Fracture Risk Reduction in Adults With Osteogenesis Imperfecta.true1Director, Division of Pediatric Nephrology Director, Division of Pediatric Nephrology true1Research Faculty PhDResearch Faculty PhDtrue1Pediatric NephrologyPediatric Nephrologytrue1Medical Director, Office of Faculty Affairs and DevelopmentMedical Director, Office of Faculty Affairs and Development